The S-5! Clamp family – one for every occasion.

MilliporeSigma held topping-out ceremony for its new membrane production plant in Darmstadt, Germany.

With this new facility, the company intends to expand manufacturing of Millipore Express membranes.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

These members serve as essential elements in Millipore Express filters and help in providing sterility of biological drug products.

This project, with an investment of over $165m, is part of the overall $1.2bn investment in the firm’s global headquarters until 2025.

The investment was announced in 2019 by MilliporeSigma’s parent company, Merck KGaA.
Merck KGaA chairman of the executive board and CEO Stefan Oschmann said: “As a science and technology company, we want to pave the way for new therapies and contribute to improving the lives of patients around the world.

“With this strategically important production facility for our Life Science business sector, we are investing in future technologies, enabling additional growth and creating new jobs at our company’s global headquarters.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

MilliporeSigma interim CEO Chris Ross said: “As a world-leading life science tools and solutions provider, we play a pivotal role in the growing biopharmaceutical membrane market.

“This investment increases our membrane manufacturing capacity and allows for more supply chain diversification. It also demonstrates our commitment to advancing the production of new therapies and our support for bringing important drugs to market.”

The new four-story membrane facility is expected to create around 55 new jobs.

Construction works commenced in March and is expected to be completed in 2022, following which there would production process validation and commercialisation.

The new facility will feature immersion membrane casting equipment, quality control laboratories and offices.

It will manufacture Millipore Express membranes, which will be then processed into filters for pharmaceutical production at MilliporeSigma’s existing device Center of Excellence in Jaffrey, New Hampshire.

Millipore Express membranes and Durapore membranes are currently manufactured at the Center of Excellence in Cork, Ireland.

—————————————————————————————————————–

MilliporeSigma plays a pivotal role in the growing biopharmaceutical membrane market. This investment demonstrates the company’s commitment to advancing the production of new therapies and its support for bringing important drugs to market. (Credit: PR Newswire Association LLC.)